Vaccine Development Immune Response Vaccine Research Vaccine Efficacy Antibodies Vaccine Safety Vaccines Immune Cells Immune System Cytokines Viral Infections Epidemiology Cell Biology Academic Leadership Immune System Disorders T Cells Research Innate Immunity Allergic Reactions Antibody Development Infectious Diseases Complement System Natural Immunity Research Immunologists Allergen Interaction Antiviral Research Innate Immune Response Autoimmunity T Cell Biology Therapeutic Innovations Viral Structure American Scientists B Cells Allergen Identification Immunological Response Autoantibodies T Cell Therapy Immunity Polyclonal Antibodies Cell Engineering Vaccine Technology T-cell Reprogramming Viral Evolution Influenza Viruses Antibody Production Chemokine Receptors T Cell Tolerance Child Immunity Antibody Response Allergy Research Hormonal Influence Vaccination Science Gobardhan Das Complement Proteins Inflammatory Responses Cellular Responses Research and Development Innate Immune System T Cell Immunity Immune cells T Cell Responses Viral Pathogens T cells
New mechanistic data show broader, more durable B cell responses with wider antibody recognition that may explain reported Phase 3 effectiveness.
